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We have developed a mathematical model for the mechanistic defects that 
underlie observed pathologies that lead to type 2 diabetes (T2D), such as 
impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).  We have 
applied the model to study the natural history of progression to T2D as reported 
in the Baltimore Longitudinal Study of Aging (BLSA).  It has been suggested that 
IGT is associated with peripheral insulin resistance and IFG with hepatic insulin 
resistance.  We tested this by simulating subjects on a continuum from high 
peripheral resistance/low hepatic resistance to low peripheral resistance/high 
hepatic resistance.  The model simulations confirm that association.  The 
simulations show further that those who present first with IGT will progress to 
combined glucose impairment (CGI, i.e. IGT and IFG) and then to T2D, provided 
insulin secretion is sufficiently impaired.   Those presenting first with IFG  
similarly tend to exhibit CGI on the path to T2D.  The BLSA study raised the 
question of whether CGI is an obligatory stage between IGT and T2D.   The model 
indicates that at the extreme of high peripheral resistance/low hepatic resistance, 
they may proceed directly from IGT to T2D without experiencing CGI.  In other 
words, two-hour glucose may exceed the threshold for T2D while fasting glucose 
remains normal.  This shows the importance of not basing T2D diagnosis solely 
on fasting glucose, but rather to also use oral glucose tolerance tests or possibly 
HbA1C.  In summary, the model is able to recapitulate the diverse pathways to 
T2D that are seen clinically.  Much of the natural variation can be captured simply 
by inversely varying peripheral and hepatic insulin resistance.   More detailed 
analysis that takes into account a second dimension of impairment in basal 
insulin secretion is needed to account for the diverse pathways seen in different 
ethnic populations. 
